Results 171 to 180 of about 132,395 (346)

Successful Management of a Refractory Orbital Pseudocyst in a Chinese Goose Using Intraorbital Gentamicin Injection

Veterinary Ophthalmology, EarlyView.
ABSTRACT Objective To report the successful management of recurrent orbital swelling in a Chinese goose (Anser cygnoides ) following evisceration surgery, utilizing intraorbital gentamicin injection after multiple unsuccessful interventions. Animal Studied A 3‐year‐old, 4.58 kg male Chinese goose (Anser cygnoides ).
Kristopher Houston, Chloe Fontaine, Natalia Dziedzic‐Nyrka, David Donaldson   +3 more
wiley   +1 more source

Safety and effectiveness of brolucizumab in patients with neovascular age-related macular degeneration: A phase IV study from India

Indian Journal of Ophthalmology
Purpose: The purpose of this study is to evaluate the safety and effectiveness of brolucizumab intravitreal injections (IVI) in Indian patients with neovascular age-related macular degeneration (nAMD).
Asim K Ghosh, Debdulal Chakraborty, Aditya Sudhalkar, Rohan Chawla, Simar R Singh, Atul K Sahu, Ramesh Venkatesh, Vishal Raval, Sonali Shah, Padma Preetha, Maulik Bhavsar, Sandip Patil, Isha Khadke, Anup Thorat   +13 more
doaj   +1 more source

Effect of intravitreal dexamethasone implant (Ozurdex®) injections on corneal biomechanical properties measured by using Ocular Response Analyzer (ORA)

, 2022
İlayda Korkmaz
openalex   +1 more source

Surgical Approaches to Retinal Gene Therapy: 2025 Update

Bioengineering
Gene therapy offers a promising new frontier in the treatment of inherited and acquired retinal disease. This review describes the current surgical delivery approaches for gene therapy to the retina—subretinal, suprachoroidal, and intravitreal—and ...
Milin J. Patel, Sohum Sheth, Jessica Mar, Ninel Z. Gregori, Jesse D. Sengillo   +4 more
doaj   +1 more source

Suprachoroidal versus Intravitreal Triamcinolone Acetonide for the Treatment of Diabetic Macular Edema

, 2022
Yousra Gamal Zakaria, Abdelrahman Gaber Salman, Azza Said, Mona Kamal Abdelatif   +3 more
openalex   +2 more sources

Cell and Gene Therapy in Equine Ocular Disease

Veterinary Ophthalmology, Volume 29, Issue 2, March 2026.
ABSTRACT Equine ocular disease is common and often challenging to treat using traditional methods. This has led to the development of new therapies. Like human medicine, veterinary medicine is adopting cellular and gene therapy as innovative approaches. Equine ocular disease is a particularly promising area for these techniques.
Kimberly A. S. Young, Lauren V. Schnabel, Brian C. Gilger   +2 more
wiley   +1 more source

FeDSNP‐Pa Nanoassemblies: A Triple‐Action Therapeutic Strategy Targeting Oxidative Stress, Inflammation, and Pyroptosis for Retinal Ganglion Cell Protection in Glaucoma

Advanced Functional Materials, Volume 36, Issue 11, 5 February 2026.
FeDSNP‐Pa, a metallized nanoparticle loaded with sodium pyruvate (Pa), exerts triple therapeutic effects by scavenging reactive oxygen species (ROS), suppressing inflammatory responses, and inhibiting pyroptosis signaling pathways. This multifunctional neuroprotective strategy protecting retinal ganglion cells (RGCs) from elevated intraocular pressure ...
Yukun Wu, Xue Li, Tong Wu, Dan Ji, Yugang Bai, Xuezhi Zhou   +5 more
wiley   +1 more source

Retinal progenitor cells (jCell) for retinitis pigmentosa

Frontiers in Cellular Neuroscience
ObjectiveTo assess the safety and tolerability of intravitreal injection of human retinal progenitor cells (RPCs) at multiple dose levels in adults with non-syndromic retinitis pigmentosa (RP).DesignA prospective, multicenter, open-label, single-arm ...
Jing Yang, Jing Yang, Baruch D. Kuppermann, David Liao, Mitul C. Mehta, Chinhui Hsiang, Chinhui Hsiang, Steven Menges, Steven Menges, David S. Boyer, Henry Klassen, Henry Klassen   +11 more
doaj   +1 more source

Intravitreal hydrogels for sustained release of therapeutic proteins.

Journal of Controlled Release, 2020
Blessing C. Ilochonwu, A. Urtti, W. Hennink, T. Vermonden   +3 more
semanticscholar   +1 more source

Implantable Drug Delivery Systems for Skeletal Muscles and Eyes

Advanced NanoBiomed Research, Volume 6, Issue 2, February 2026.
This review highlights the different types of recent implantable drug delivery systems (IDDS) fabricated for a use with skeletal muscles, and with eyes. It presents the developments already made and the current research directions, showing the evolution of IDDS and their great diversity.
Serge Ostrovidov, Murugan Ramalingam, Hongkai Wu, Toshinori Fujie, Yukinari Nakamura, Takeshi Hori, Yuji Nashimoto, Xuetao Shi, Hirokazu Kaji   +8 more
wiley   +1 more source